Technical Analysis for EVO - Evotec SE

Grade Last Price % Change Price Change
C 22.99 2.54% 0.57
EVO closed up 2.54 percent on Tuesday, December 7, 2021, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical EVO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup 2.54%
Narrow Range Bar Range Contraction 2.54%
Stochastic Reached Oversold Weakness 2.54%
Lower Bollinger Band Touch Weakness 2.54%
Oversold Stochastic Weakness 2.54%
Hot IPO Pullback Bullish Swing Setup 2.18%
Older End-of-Day Signals for EVO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
Possible NR7 about 12 hours ago
Gapped Up (Full) about 16 hours ago
Hot IPO Pullback Entry about 16 hours ago
Rose Above Previous Day's High about 16 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Evotec is an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Evotec's mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with our partners. Evotec has built a comprehensive suite of fully integrated, next generation technology platforms which it believes will transform the way new drugs are discovered. By leveraging the advanced capabilities of Evotec's integrated platforms, Evotec is able to provide solutions to its partners that enable significant improvements in the quality of new drugs while accelerating the drug discovery process and reducing the high cost of attrition often associated with traditional drug discovery processes.

Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Keywords: Biotechnology Life Sciences Pharmaceutical Industry Diseases Health Sciences Natural Sciences Medication Drug Discovery Drug Evotec

Is EVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 24.36
52 Week Low 20.9
Average Volume 306,578
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 23.32
10-Day Moving Average 23.11
Average True Range 0.86
ADX 0.0
+DI 26.76
-DI 24.32
Chandelier Exit (Long, 3 ATRs) 21.78
Chandelier Exit (Short, 3 ATRs) 23.48
Upper Bollinger Bands 24.27
Lower Bollinger Band 22.37
Percent B (%b) 0.33
BandWidth 8.18
MACD Line -0.19
MACD Signal Line -0.08
MACD Histogram -0.1079
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.47
Resistance 3 (R3) 23.46 23.30 23.39
Resistance 2 (R2) 23.30 23.17 23.30 23.36
Resistance 1 (R1) 23.14 23.10 23.22 23.15 23.34
Pivot Point 22.98 22.98 23.02 22.98 22.98
Support 1 (S1) 22.82 22.85 22.90 22.83 22.64
Support 2 (S2) 22.66 22.78 22.66 22.62
Support 3 (S3) 22.50 22.66 22.59
Support 4 (S4) 22.51